Skip to main content
ImmuneCited

Vitamin D के लिए Upper Respiratory Tract Infections

A

Lancet 2025 meta-analysis shows vitamin D supplementation may help protect against acute respiratory infections, with strongest effects in individuals with baseline 25(OH)D levels below 25 nmol/L. Optimal protective dosing appears to be 400-1,200 IU/day rather than intermittent bolus dosing.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'immunecited.com'; const params = 'ingredient\u003Dvitamin\u002Dd\u0026condition\u003Dupper\u002Drespiratory\u002Dinfections'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

A

निष्कर्ष

Lancet 2025 meta-analysis shows vitamin D supplementation may help protect against acute respiratory infections, with strongest effects in individuals with baseline 25(OH)D levels below 25 nmol/L. Optimal protective dosing appears to be 400-1,200 IU/day rather than intermittent bolus dosing.

Key Study Findings

Review
UCI Sports Nutrition Project: The Role of Nutrition in the Prevention and Management of Illnesses …
Dose: None बनाम: None Outcome: None प्रभाव: None None

जनसंख्या: Elite/professional cyclists nutrition review

Systematic Review
Interventions for preventing the progression of autosomal dominant polycystic kidney disease.
Dose: Disease-modifying agents (tolvaptan, etc.) बनाम: Placebo or standard care Outcome: Kidney disease progression प्रभाव: None None

जनसंख्या: Patients with ADPKD

Review
Nutraceuticals and pharmacological to balance the transitional microbiome to extend immunity during COVID-19 and other …
Dose: Probiotics, nutraceuticals बनाम: None Outcome: Immune response modulation in COVID-19 प्रभाव: None None

जनसंख्या: COVID-19 patients with gut dysbiosis

Review
Revisiting Vitamin D Guidelines: A Critical Appraisal of the Literature.
Dose: 600-800 IU (DRI) or higher बनाम: None Outcome: Skeletal and extra-skeletal health benefits प्रभाव: None None

जनसंख्या: General population (guideline comparison)

Meta-Analysis n=5748
High-dose oral vitamin D supplementation for prevention of infections in children aged 0 to 59 …
Dose: 400 IU बनाम: Placebo Outcome: None प्रभाव: None None

जनसंख्या: Healthy adults

Case-Control 26.0 weeks
Vitamin D - An Elixir for Recurrent Upper Respiratory Tract Infection.
Dose: 98% बनाम: control Outcome: None प्रभाव: None None

जनसंख्या: None

Key Statistics

40

अध्ययन

30000

प्रतिभागी

Positive

A

ग्रेड

Referenced Papers

Endocrine practice : … 2024 24 उद्धरण
The Cochrane database … 2024 1 उद्धरण
Dermatologic therapy 2022 42 उद्धरण
European archives of … 2019 14 उद्धरण
International journal of … 2018 165 उद्धरण
European journal of … 2016 93 उद्धरण
American journal of … 2016 45 उद्धरण
Journal of general … 2016 38 उद्धरण
Indian journal of … 2013 24 उद्धरण
Acta scientiarum polonorum. … 2012 11 उद्धरण
International journal of … 2011 49 उद्धरण
The Journal of … 2010 93 उद्धरण
Journal of the … 2010 11 उद्धरण
Clinical journal of … 2008 148 उद्धरण
International journal of … 2002 26 उद्धरण
Diseases of the … 2001 7 उद्धरण

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

सामान्य रूप से उपयोग की जाने वाली खुराकें

general:
600-800 IU/day
immunesupport:
1,000-2,000 IU/day
deficiencycorrection:
4,000-5,000 IU/day (under medical supervision)

अधिकतम सीमा: 4,000 IU/day (100 mcg)

अनुसंधान में अध्ययन की गई खुराकें

खुराक अवधि प्रभाव N
None -- Mixed --
Disease-modifying agents (tolvaptan, etc.) -- Positive --
Probiotics, nutraceuticals -- Positive --
600-800 IU (DRI) or higher -- Positive --
400 IU -- Negative 5748
98% 26.0 weeks Mixed --
None -- Positive --
None -- Positive 50554

सेवन का सर्वोत्तम समय: With a meal containing fat for better absorption

Safety & Side Effects

रिपोर्ट किए गए दुष्प्रभाव

  • Hypercalcemia at very high doses (nausea, vomiting, weakness)
  • Kidney stones with excessive long-term use
  • Constipation
  • Metallic taste

ज्ञात अंतःक्रियाएँ

  • Thiazide diuretics (may increase risk of hypercalcemia)
  • Corticosteroids (reduce vitamin D absorption and metabolism)
  • Orlistat and cholestyramine (reduce fat-soluble vitamin absorption)
  • Statins (vitamin D may affect statin metabolism)

सहनीय अधिकतम सेवन: 4,000 IU/day (100 mcg)

कोई भी सप्लीमेंट शुरू करने से पहले हमेशा अपने स्वास्थ्य सेवा प्रदाता से परामर्श करें।

Frequently Asked Questions

Does Vitamin D help with Upper Respiratory Tract Infections?
Based on 40 studies with 30,000 participants, there is strong evidence from multiple clinical trials that Vitamin D may support Upper Respiratory Tract Infections management. Our evidence grade is A (Strong Evidence).
How much Vitamin D should I take for Upper Respiratory Tract Infections?
Studies have used various dosages. A commonly studied range is 600-800 IU/day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Vitamin D?
Reported side effects may include Hypercalcemia at very high doses (nausea, vomiting, weakness), Kidney stones with excessive long-term use, Constipation, Metallic taste. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Vitamin D and Upper Respiratory Tract Infections?
We rate the evidence as Grade A (Strong Evidence). This rating is based on 40 peer-reviewed studies with 30,000 total participants. The overall direction of effect is positive.

Related Evidence

इसके लिए अन्य सामग्री Upper Respiratory Tract Infections

Vitamin D अन्य स्वास्थ्य स्थितियों के लिए

FDA अस्वीकरण: इन कथनों का Food and Drug Administration द्वारा मूल्यांकन नहीं किया गया है। इस वेबसाइट पर उत्पादों और जानकारी का उद्देश्य किसी बीमारी का निदान, उपचार, इलाज या रोकथाम नहीं है। प्रस्तुत साक्ष्य ग्रेड प्रकाशित पीयर-रिव्यूड अनुसंधान के हमारे विश्लेषण पर आधारित हैं और चिकित्सा सलाह नहीं हैं। कोई भी सप्लीमेंट शुरू करने से पहले हमेशा अपने स्वास्थ्य सेवा प्रदाता से परामर्श करें।